Navigation Links
Initial Evaluation of New Nucleus Removal Device Provides Promising Results

CoreSpine Technologies' device evaluated in cadaver by leading spine


MINNEAPOLIS, Oct. 18 /PRNewswire/ -- CoreSpine Technologies LLC, an emerging spinal device company located in Minneapolis, Minnesota announced today the completion of the company's initial cadaver evaluations.

CoreSpine's first product in development is a complete nucleus removal device that seeks to remove the nucleus pulposus from the lumbar disc space, while not damaging the annulus or endplates. In addition, its design characteristics allow the device to be used in multiple surgical approaches, including the preferred posterior approach.

"This set of successful evaluations illustrates that the prototype has made progress towards a device that addresses the clinical needs for safe and complete nucleus resection," said John Sherman, M.D., Medical Director for CoreSpine. Dr. Sherman continued, "The device created a larger nucleus cavity than the rongeur and damage to the annulus and endplates was minimized."

"We're pleased with the data that was generated from the labs. As Dr. Sherman stated, the results of the initial work are promising and will be used to guide the near-term engineering refinements, "said Britt Norton, Co-Founder of CoreSpine Technologies. Mr. Norton continued, "CoreSpine has submitted data and information for presentation at international spine meetings in 2008."

About CoreSpine Technologies, LLC

CoreSpine Technologies is a privately held medical device company. It is focused solely on the design and development of improved nucleus removal devices, which will be a crucial step in the optimum placement of nucleus replacement and minimally invasive fusion implants. CoreSpine's first products will mechanically remove the nucleus from the lumbar disc space, while sparing annulus and endplate tissues. For additional information, please contact Christine Horton at or Britt Norton at, or visit the company's website at

SOURCE CoreSpine Technologies, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Detecting Lung Cancer In Its Initial Stages
2. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
3. Initial Steps In Spread Of Cancer Identified
4. Initial tests negative for bird flu in Romanian Woman
5. Probe into Pascal Norris’s death finds initial samples free of anthrax germ
6. Elastrography, may Call the Shots During Initial Stage of Breast Screening
7. A New Evaluation Tool That Could Predict Death Risk in Heart Patients
8. Dietary supplementation of Folic Acid Requires Critical Evaluation
9. Re-evaluation of the soy protein’s effects to reduce cholestero
10. The Face Of Indian Health Care: A World Health Day Evaluation
11. Ohio Tobacco Research and Evaluation Center To Be Developed By Case
Post Your Comments:
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: